The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults
- DOI
- 10.1016/j.vaccine.2026.128970
- Published
- 2026-08
- Container
- Vaccine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.128970,
title = {The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults},
author = {McLeod C. and M. Dymock and K.L. Flanagan and M. Plebanski and H. Marshall and M.J. Estcourt and M.C. Tjiam and C.C. Blyth and K. Subbarao and F.L. Mordant and K. Wilson and S. Nicholson and T. Karapanagiotidis and S.N. Faust and U. Wadia and R.B. Thornton and S. Tansil and C. Tedja and Z. Ellis and P.C.M. Williams and A. McKenzie and J.A. Marsh and C. McCallum and T.L. Snelling and P. Richmond},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.128970},
url = {https://doi.org/10.1016/j.vaccine.2026.128970}
}RIS
TY - JOUR TI - The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults AU - McLeod C. AU - M. Dymock AU - K.L. Flanagan AU - M. Plebanski AU - H. Marshall AU - M.J. Estcourt AU - M.C. Tjiam AU - C.C. Blyth AU - K. Subbarao AU - F.L. Mordant AU - K. Wilson AU - S. Nicholson AU - T. Karapanagiotidis AU - S.N. Faust AU - U. Wadia AU - R.B. Thornton AU - S. Tansil AU - C. Tedja AU - Z. Ellis AU - P.C.M. Williams AU - A. McKenzie AU - J.A. Marsh AU - C. McCallum AU - T.L. Snelling AU - P. Richmond PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.128970 UR - https://doi.org/10.1016/j.vaccine.2026.128970 ER -
APA
C., M., Dymock, M., Flanagan, K., Plebanski, M., Marshall, H., Estcourt, M., Tjiam, M., Blyth, C., Subbarao, K., Mordant, F., Wilson, K., Nicholson, S., Karapanagiotidis, T., Faust, S., Wadia, U., Thornton, R., Tansil, S., Tedja, C., Ellis, Z., Williams, P., McKenzie, A., Marsh, J., McCallum, C., Snelling, T., & Richmond, P. (2026). The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128970
Source records
- crossref · retrieved 2026-09-26T03:59:07.816Z